UY25711A1 - Administración de agente activo en polvo seco - Google Patents

Administración de agente activo en polvo seco

Info

Publication number: UY25711A1
Authority: UY; Uruguay
Prior art keywords: particles; active agent; growth inhibitor; administration; alveoli
Prior art date: 1998-09-14

Application number

UY25711A

Other languages

English (en)

Spanish (es)

Inventor

John Aldous Barry

Original Assignee

Inhale Therapeutics Systems Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-14

Filing date

1999-09-14

Publication date

1999-11-17

1999-09-14 Application filed by Inhale Therapeutics Systems Inc filed Critical Inhale Therapeutics Systems Inc

1999-11-17 Publication of UY25711A1 publication Critical patent/UY25711A1/es

Links

239000013543 active substance Substances 0.000 title abstract 8
239000002245 particle Substances 0.000 abstract 12
239000003966 growth inhibitor Substances 0.000 abstract 5
210000004072 lung Anatomy 0.000 abstract 2
BLUGYPPOFIHFJS-UUFHNPECSA-N (2s)-n-[(2s)-1-[[(3r,4s,5s)-3-methoxy-1-[(2s)-2-[(1r,2r)-1-methoxy-2-methyl-3-oxo-3-[[(1s)-2-phenyl-1-(1,3-thiazol-2-yl)ethyl]amino]propyl]pyrrolidin-1-yl]-5-methyl-1-oxoheptan-4-yl]-methylamino]-3-methyl-1-oxobutan-2-yl]-3-methyl-2-(methylamino)butanamid Chemical compound CN[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N(C)[C@@H]([C@@H](C)CC)[C@H](OC)CC(=O)N1CCC[C@H]1[C@H](OC)[C@@H](C)C(=O)N[C@H](C=1SC=CN=1)CC1=CC=CC=C1 BLUGYPPOFIHFJS-UUFHNPECSA-N 0.000 abstract 1
208000007934 ACTH-independent macronodular adrenal hyperplasia Diseases 0.000 abstract 1
229920000858 Cyclodextrin Polymers 0.000 abstract 1
229920002307 Dextran Polymers 0.000 abstract 1
229920001605 Dextranomer Polymers 0.000 abstract 1
239000001856 Ethyl cellulose Substances 0.000 abstract 1
ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 abstract 1
229920001612 Hydroxyethyl starch Polymers 0.000 abstract 1
229920002153 Hydroxypropyl cellulose Polymers 0.000 abstract 1
239000000443 aerosol Substances 0.000 abstract 1
239000003795 chemical substances by application Substances 0.000 abstract 1
229940097362 cyclodextrins Drugs 0.000 abstract 1
229960002086 dextran Drugs 0.000 abstract 1
229960002864 dextranomer Drugs 0.000 abstract 1
MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 abstract 1
229920001249 ethyl cellulose Polymers 0.000 abstract 1
235000019325 ethyl cellulose Nutrition 0.000 abstract 1
229940050526 hydroxyethylstarch Drugs 0.000 abstract 1
239000001863 hydroxypropyl cellulose Substances 0.000 abstract 1
235000010977 hydroxypropyl cellulose Nutrition 0.000 abstract 1
239000001866 hydroxypropyl methyl cellulose Substances 0.000 abstract 1
229920003088 hydroxypropyl methyl cellulose Polymers 0.000 abstract 1
235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 abstract 1
UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 abstract 1
-1 maltodextran Polymers 0.000 abstract 1
150000003904 phospholipids Chemical class 0.000 abstract 1
239000000843 powder Substances 0.000 abstract 1
230000002685 pulmonary effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Otolaryngology (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Solid-Sorbent Or Filter-Aiding Compositions (AREA)

UY25711A 1998-09-14 1999-09-14 Administración de agente activo en polvo seco UY25711A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US10016398P	1998-09-14	1998-09-14

Publications (1)

Publication Number	Publication Date
UY25711A1 true UY25711A1 (es)	1999-11-17

Family

ID=22278404

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
UY25711A UY25711A1 (es)	1998-09-14	1999-09-14	Administración de agente activo en polvo seco

Country Status (44)

Country	Link
EP (1)	EP1117442A1 (fr)
JP (1)	JP2002524535A (fr)
KR (1)	KR20010075063A (fr)
CN (1)	CN1317977A (fr)
AP (1)	AP1374A (fr)
AR (1)	AR022090A1 (fr)
AU (1)	AU753014B2 (fr)
BG (1)	BG105430A (fr)
BR (1)	BR9913722A (fr)
CA (1)	CA2343920A1 (fr)
CO (1)	CO5130023A1 (fr)
CZ (1)	CZ2001829A3 (fr)
DZ (1)	DZ2892A1 (fr)
EA (1)	EA003476B1 (fr)
EE (1)	EE200100151A (fr)
GE (1)	GEP20043257B (fr)
GT (1)	GT199900156A (fr)
HK (1)	HK1042231A1 (fr)
HN (1)	HN1999000159A (fr)
HR (1)	HRP20010189A2 (fr)
HU (1)	HUP0103837A3 (fr)
ID (1)	ID28845A (fr)
IL (2)	IL141562A0 (fr)
IS (1)	IS5878A (fr)
LT (1)	LT4897B (fr)
LV (1)	LV12658B (fr)
MA (1)	MA25590A1 (fr)
MY (1)	MY129282A (fr)
NO (1)	NO20011251L (fr)
NZ (1)	NZ510168A (fr)
OA (1)	OA11781A (fr)
PA (1)	PA8481901A1 (fr)
PE (1)	PE20001061A1 (fr)
PL (1)	PL195574B1 (fr)
SA (1)	SA99200718B1 (fr)
SK (1)	SK3442001A3 (fr)
TN (1)	TNSN99173A1 (fr)
TR (1)	TR200101182T2 (fr)
TW (1)	TWI226248B (fr)
UA (1)	UA76085C2 (fr)
UY (1)	UY25711A1 (fr)
WO (1)	WO2000015262A1 (fr)
YU (1)	YU24201A (fr)
ZA (1)	ZA200101995B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6956021B1 (en)	1998-08-25	2005-10-18	Advanced Inhalation Research, Inc.	Stable spray-dried protein formulations
JP4874483B2 (ja)	1999-06-09	2012-02-15	ロバートイー．シーバース	超臨界流体補助ネブライゼーション及びバブル乾燥
US6475468B2 (en) *	2001-02-15	2002-11-05	Aeropharm Technology Incorporated	Modulated release particles for aerosol delivery
CA2446904A1 (fr) *	2001-05-24	2003-04-03	Alexza Molecular Delivery Corporation	Administration d'esters medicamenteux par inhalation
EG24184A (en)	2001-06-15	2008-10-08	Otsuka Pharma Co Ltd	Dry powder inhalation system for transpulmonary
CA2465675C (fr)	2001-11-20	2008-06-10	Advanced Inhalation Research, Inc.	Compositions particulaires ameliorees destinees a etre administrees par voie pulmonaire
US7759506B2 (en)	2002-02-25	2010-07-20	Diffusion Pharmaceuticals Llc	Bipolar trans carotenoid salts and their uses
UA83341C2 (uk)	2002-02-25	2008-07-10	Дифьюжен Фармасьютикалз Ллк	Біополярні солі транс-каротиноїдів та їх використання
AU2003232081B2 (en) *	2002-07-03	2009-02-05	Brandeis University	Central airway administration for systemic delivery of therapeutics
CA2511385A1 (fr) *	2002-12-19	2004-07-22	Pharmacia Corporation	Intermediaire pour formulation a caractere non-hygroscopique acceptable comprenant un bouchon hydroscopique
DE10338403A1 (de) *	2003-08-18	2005-03-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Pulverformulierung, enthaltend den CGRP-Antagonisten 1-[N2-[3,5-Dibrom-N-[[4-(3,4-dihydro-2(1H)-oxochinazolin-3-yl]-1-piperidinyl]carbonyl]-D-tyrosyl]-L-lysyl]-4-(4-pyrindinyl)-piperazin, Verfahren zu dessen Herstellung sowie dessen Verwendung als Inhalativum
GB0327723D0 (en) *	2003-09-15	2003-12-31	Vectura Ltd	Pharmaceutical compositions
US20070020299A1 (en)	2003-12-31	2007-01-25	Pipkin James D	Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
ES2909080T3 (es)	2004-04-23	2022-05-05	Cydex Pharmaceuticals Inc	Formulación de DPI que contiene sulfoalquil éter ciclodextrina
US8030350B2 (en)	2005-02-24	2011-10-04	Diffusion Pharmaceuticals Llc	Trans carotenoids, their synthesis, formulation and uses
BRPI0608844A2 (pt) *	2005-03-09	2010-02-02	Ono Pharmaceutical Co	partìcula e preparação que contém a partìcula
ES2526903T3 (es)	2005-10-26	2015-01-16	Cydex Pharmaceuticals, Inc.	Composiciones de sulfoalquiléter ciclodextrina y métodos de preparación de las mismas
US7629331B2 (en)	2005-10-26	2009-12-08	Cydex Pharmaceuticals, Inc.	Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US20080035143A1 (en) *	2006-08-14	2008-02-14	Sievers Robert E	Human-powered dry powder inhaler and dry powder inhaler compositions
KR20090081407A (ko) *	2006-10-25	2009-07-28	다이닛본 스미토모 세이야꾸 가부시끼가이샤	고결 방지 과립상 제제
EP1925295A1 (fr) *	2006-11-22	2008-05-28	Boehringer Ingelheim Pharma GmbH & Co. KG	Formule de poudre stable contenant un nouveau anticholinergique
MX2009010988A (es)	2007-04-13	2010-03-15	Diffusion Pharmaceuticals Llc	Uso de trans-carotenoides bipolares como un tratamiento previo y en el tratamiento de una enfermedad vascular periferica.
US12370352B2 (en)	2007-06-28	2025-07-29	Cydex Pharmaceuticals, Inc.	Nasal and ophthalmic delivery of aqueous corticosteroid solutions
MX2010004803A (es)	2007-10-31	2010-09-09	Diffusion Pharmaceuticals Llc	Una nueva clase de composiciones terapeuticas que mejoran la difusion de moleculas pequeñas.
US9610343B2 (en) *	2009-05-20	2017-04-04	Aeras Global Tb Vaccine Foundation	Stable, spray dryed, immunogenic, viral compositions
EP2445339B1 (fr)	2009-06-22	2019-08-07	Diffusion Pharmaceuticals LLC	Composé améliorant la diffusion et son utilisation avec un thrombolytique
ES2654945T3 (es)	2010-06-02	2018-02-15	Diffusion Pharmaceuticals Llc	Formulaciones orales de carotenoides trans bipolares
US9682096B2 (en)	2012-05-02	2017-06-20	Janssen R & D Ireland	Polyinosinic-polycytidylic acid (poly (I:C)) formulations for the treatment of upper respiratory tract infections
WO2014074797A1 (fr) *	2012-11-09	2014-05-15	Civitas Therapeutics, Inc.	Poudres pulmonaires de densité ultra basse
WO2015042352A1 (fr) *	2013-09-20	2015-03-26	Virginia Commonwealth University	Administration de particules à l'aide d'excipients hygroscopiques
CA2965759C (fr)	2014-10-31	2023-12-12	Glaxosmithkline Intellectual Property Development Limited	Polypeptides en poudre presentant moins d'impuretes de disulfide comprenant des materiaux cationiques divalents
WO2017165667A1 (fr)	2016-03-24	2017-09-28	Diffusion Pharmaceuticals Llc	Utilisation de caroténoïdes trans bipolaires avec une chimiothérapie et une radiothérapie en vue du traitement d'un cancer
US20220378727A1 (en) *	2021-05-14	2022-12-01	The University Of Hong Kong	Dry powder formulations of tamibarotene for pulmonary and intranasal delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3155573A (en) *	1958-05-06	1964-11-03	Benger Lab Ltd	Inhalant composition and method of making same
ATE222754T1 (de) *	1992-06-12	2002-09-15	Teijin Ltd	Ultrafeines pulver zur inhalation und dessen herstellung
US6524557B1 (en) *	1994-12-22	2003-02-25	Astrazeneca Ab	Aerosol formulations of peptides and proteins
US5874064A (en)	1996-05-24	1999-02-23	Massachusetts Institute Of Technology	Aerodynamically light particles for pulmonary drug delivery
WO1998031346A1 (fr) *	1997-01-16	1998-07-23	Massachusetts Institute Of Technology	Preparation de particules pour inhalation
US6086376A (en) *	1998-01-30	2000-07-11	Rtp Pharma Inc.	Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

1999
- 1999-09-09 MA MA25762A patent/MA25590A1/fr unknown
- 1999-09-13 CA CA002343920A patent/CA2343920A1/fr not_active Abandoned
- 1999-09-13 EE EEP200100151A patent/EE200100151A/xx unknown
- 1999-09-13 IL IL14156299A patent/IL141562A0/xx not_active IP Right Cessation
- 1999-09-13 NZ NZ510168A patent/NZ510168A/en unknown
- 1999-09-13 WO PCT/US1999/021109 patent/WO2000015262A1/fr not_active Ceased
- 1999-09-13 UA UA2001031707A patent/UA76085C2/uk unknown
- 1999-09-13 TW TW088115876A patent/TWI226248B/zh not_active IP Right Cessation
- 1999-09-13 OA OA1200100063A patent/OA11781A/en unknown
- 1999-09-13 JP JP2000569846A patent/JP2002524535A/ja not_active Withdrawn
- 1999-09-13 HN HN1999000159A patent/HN1999000159A/es unknown
- 1999-09-13 DZ DZ990192A patent/DZ2892A1/fr active
- 1999-09-13 ID IDW20010582A patent/ID28845A/id unknown
- 1999-09-13 EP EP99969035A patent/EP1117442A1/fr not_active Withdrawn
- 1999-09-13 AR ARP990104587A patent/AR022090A1/es unknown
- 1999-09-13 CZ CZ2001829A patent/CZ2001829A3/cs unknown
- 1999-09-13 AU AU60397/99A patent/AU753014B2/en not_active Ceased
- 1999-09-13 PE PE1999000925A patent/PE20001061A1/es not_active Application Discontinuation
- 1999-09-13 CN CN99810871A patent/CN1317977A/zh active Pending
- 1999-09-13 YU YU24201A patent/YU24201A/sh unknown
- 1999-09-13 AP APAP/P/2001/002093A patent/AP1374A/en active
- 1999-09-13 GE GEAP19995857A patent/GEP20043257B/en unknown
- 1999-09-13 TR TR2001/01182T patent/TR200101182T2/xx unknown
- 1999-09-13 BR BR9913722-4A patent/BR9913722A/pt not_active IP Right Cessation
- 1999-09-13 SK SK344-2001A patent/SK3442001A3/sk unknown
- 1999-09-13 HU HU0103837A patent/HUP0103837A3/hu unknown
- 1999-09-13 KR KR1020017003208A patent/KR20010075063A/ko not_active Ceased
- 1999-09-13 HR HR20010189A patent/HRP20010189A2/hr not_active Application Discontinuation
- 1999-09-13 HK HK02101738.3A patent/HK1042231A1/zh unknown
- 1999-09-13 MY MYPI99003947A patent/MY129282A/en unknown
- 1999-09-13 ZA ZA200101995A patent/ZA200101995B/en unknown
- 1999-09-13 EA EA200100300A patent/EA003476B1/ru active IP Right Revival
- 1999-09-13 PL PL99346768A patent/PL195574B1/pl not_active IP Right Cessation
- 1999-09-14 PA PA19998481901A patent/PA8481901A1/es unknown
- 1999-09-14 TN TNTNSN99173A patent/TNSN99173A1/fr unknown
- 1999-09-14 GT GT199900156A patent/GT199900156A/es unknown
- 1999-09-14 CO CO99058265A patent/CO5130023A1/es unknown
- 1999-09-14 UY UY25711A patent/UY25711A1/es not_active Application Discontinuation
- 1999-10-31 SA SA99200718A patent/SA99200718B1/ar unknown
2001
- 2001-02-21 IL IL141562A patent/IL141562A/en unknown
- 2001-03-05 IS IS5878A patent/IS5878A/is unknown
- 2001-03-13 NO NO20011251A patent/NO20011251L/no not_active Application Discontinuation
- 2001-03-14 LT LT2001021A patent/LT4897B/lt not_active IP Right Cessation
- 2001-03-14 LV LV010041A patent/LV12658B/xx unknown
- 2001-04-10 BG BG105430A patent/BG105430A/xx unknown

Also Published As

Publication number	Publication date
UA76085C2 (en)	2006-07-17
IS5878A (is)	2001-03-05
CN1317977A (zh)	2001-10-17
IL141562A0 (en)	2002-03-10
HUP0103837A3 (en)	2002-11-28
CZ2001829A3 (cs)	2001-09-12
KR20010075063A (ko)	2001-08-09
TWI226248B (en)	2005-01-11
PL346768A1 (en)	2002-02-25
EP1117442A1 (fr)	2001-07-25
ZA200101995B (en)	2002-03-11
HUP0103837A2 (hu)	2002-05-29
BG105430A (en)	2001-12-29
AP2001002093A0 (en)	2001-03-31
TR200101182T2 (tr)	2001-09-21
CO5130023A1 (es)	2002-02-27
MY129282A (en)	2007-03-30
GT199900156A (es)	2001-03-07
WO2000015262A1 (fr)	2000-03-23
HRP20010189A2 (en)	2005-04-30
PE20001061A1 (es)	2000-10-08
IL141562A (en)	2007-07-24
TNSN99173A1 (fr)	2005-11-10
LV12658A (lv)	2001-05-20
SA99200718B1 (ar)	2006-11-04
AR022090A1 (es)	2002-09-04
CA2343920A1 (fr)	2000-03-23
BR9913722A (pt)	2001-05-29
LT2001021A (en)	2001-11-26
PA8481901A1 (es)	2002-04-25
AP1374A (en)	2005-02-28
LT4897B (lt)	2002-02-25
EA003476B1 (ru)	2003-06-26
ID28845A (id)	2001-07-05
LV12658B (lv)	2001-09-20
NO20011251L (no)	2001-04-17
HK1042231A1 (zh)	2002-08-09
SK3442001A3 (en)	2001-11-06
JP2002524535A (ja)	2002-08-06
AU753014B2 (en)	2002-10-03
EE200100151A (et)	2002-06-17
MA25590A1 (fr)	2002-12-31
GEP20043257B (en)	2004-06-25
OA11781A (en)	2005-07-26
DZ2892A1 (fr)	2003-12-15
AU6039799A (en)	2000-04-03
EA200100300A1 (ru)	2001-10-22
NO20011251D0 (no)	2001-03-13
PL195574B1 (pl)	2007-10-31
YU24201A (sh)	2003-08-29
HN1999000159A (es)	1999-11-11
NZ510168A (en)	2003-09-26

Publication	Publication Date	Title
UY25711A1 (es)	1999-11-17	Administración de agente activo en polvo seco
AU710821B2 (en)	1999-09-30	Fluticasone propionate formulations
US8858917B2 (en)	2014-10-14	Methods for limiting spread of pulmonary infections
Conley et al.	1997	Aerosol delivery of liposome-encapsulated ciprofloxacin: aerosol characterization and efficacy against Francisella tularensis infection in mice
US20070292519A1 (en)	2007-12-20	Method of producing a nicotine medicament and a medicament made by the method
Thomson et al.	1975	No demonstrable effect of S-carboxymethylcysteine on clearance of secretions from the human lung.
CZ299348B6 (cs)	2008-06-25	Aerosolový prostredek
JP2009529561A (ja)	2009-08-20	ニコチンの速やかな放出をもたらす安定なロゼンジ組成物
KR20090055606A (ko)	2009-06-02	지향성 용도
PT756868E (pt)	2001-11-30	Composicoes em aerossois
UY23356A1 (es)	1992-02-04	Preparado para la liberacion retardada de sustancias activas, que son apropiadas como sistema terapeutico o para mejorar el crecimiento y el aprovechamiento de los piensos en rumiantes
AR018891A1 (es)	2001-12-12	Inhaladores presurizados de dosificacion medida y formulaciones farmaceuticas en aerosol
US20120042886A1 (en)	2012-02-23	Method of producing a nicotine medicament and a medicament made by the method
Moosavi et al.	1977	Early radiation dose-response in lung: an ultrastructural study
US3667478A (en)	1972-06-06	Filter cigarette incorporating vitamin a
CA3019748A1 (fr)	2017-10-12	Composition ophtalmique contenant de la pvp-i
RU2701514C2 (ru)	2019-09-27	Антивирусная фармацевтическая композиция
US9427443B2 (en)	2016-08-30	Anaesthetic composition
FI962056A0 (fi)	1996-05-15	Uusi farmaseuttinen koostumus stabiilin jauheen valmistamiseksi, joka sisältää asetyylisalisyylihapon ja metoklopramidin yhdistelmän käsittävän aktiivisen aineosan
Niven et al.	1990	Solute absorption from the airways of the isolated rat lung. II. Effect of surfactants on absorption of fluorescein
KR20140001877A (ko)	2014-01-07	흡입 데누포솔에 의한 낭포성 섬유증의 치료 방법
US20050220720A1 (en)	2005-10-06	Formulations limiting spread of pulmonary infections
JP2024128022A (ja)	2024-09-20	微生物感染を消毒、処置および予防するための組成物および方法
DK168191B1 (da)	1994-02-28	Anvendelse af peroxydiphosphater til fremstilling af farmaceutiske tabletter eller farmaceutiske vandige opløsninger
US11903925B2 (en)	2024-02-20	Compositions for preventing and treating pulmonary injury due to ionizing radiation or cytotoxic drugs

Legal Events

Date	Code	Title	Description
2008-12-03	RDES	Application refused	Effective date: 20081203